What Is CJC-1295?
A growth-hormone-releasing hormone analog studied for pulsatile GH secretion.
01Definition
CJC-1295 is a endocrine research compound. A growth-hormone-releasing hormone analog studied for pulsatile GH secretion. It is also known as Modified GRF 1-29 (no DAC).
Sequence · Modified GRF(1-29)
02Research Mechanism
CJC-1295 (without DAC) is a modified analog of growth-hormone-releasing hormone (GHRH) fragment 1-29. It acts as a GHRH-receptor agonist on pituitary somatotrophs, studied for its capacity to stimulate growth-hormone release while preserving the natural pulsatile pattern.
Research framing only · No human-use claims
03Key Facts
| Classification | Endocrine |
| Molecular weight | 3,367.8 g/mol |
| Also known as | Modified GRF 1-29 (no DAC) |
| Purity spec | ≥99% HPLC |
| Verification | MZ Biolabs · 5-panel |
| Use | Research Use Only |
04FAQ
What is CJC-1295?
CJC-1295 is a endocrine research compound. A growth-hormone-releasing hormone analog studied for pulsatile GH secretion. It is also known as Modified GRF 1-29 (no DAC). It is supplied strictly for laboratory research use.
What class of compound is CJC-1295?
CJC-1295 is categorized as Endocrine and is studied alongside related compounds in that research area.
What is the molecular weight of CJC-1295?
CJC-1295 has a molecular weight of 3,367.8 g/mol.
How is CJC-1295 tested?
Every Ethos Bio lot of CJC-1295 is analyzed by an independent third-party laboratory (MZ Biolabs, Arizona) on a five-point panel — HPLC purity, mass-spec identity, endotoxin, heavy metals, and sterility — with a batch-specific Certificate of Analysis.
View CJC-1295 product → · Full monograph → · Molecular weight →